OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
PLSM$1030.0056

Pulsenmore Ltd

Advanced Medical Equipment & TechnologyVerified

Pulsenmore Ltd maintains a strong liquidity position, with a current ratio of 7.88 and cash and equivalents of 21.6 million ILS, indicating a robust ability to meet short-term obligations. The company's debt-to-equity ratio is 0.02, reflecting a conservative capital structure with minimal leverage. However, the company's price-to-book ratio of 80.61 suggests that the market is valuing the company significantly above its book value, which may reflect high expectations for future growth or innovation. The company's profitability metrics are concerning, with a negative return on equity of -19.08% and a negative return on assets of -15.57%, indicating that it is not generating returns for shareholders or effectively utilizing its assets. These figures are below the typical performance of the Advanced Medical Equipment & Technology industry, which generally expects positive returns due to the high-margin nature of medical equipment sales and services. Pulsenmore Ltd's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher risks if demand in its primary market fluctuates or if regulatory changes impact its operations. The company's growth trajectory is mixed. While it has a strong cash position, its operating and net income are negative, and its operating cash flow is -32.88 million ILS, indicating that it is not generating sufficient cash from operations to sustain its activities. The outlook for the current fiscal year does not indicate a significant improvement in these metrics, and the company may need to rely on its cash reserves to fund operations in the near term. Risk factors for Pulsenmore Ltd include the potential for dilution, although the risk is currently assessed as low. The company has not issued additional shares recently, and there are no immediate filing-based liquidity or dilution flags. However, the company's negative net income and operating cash flow could necessitate future financing, which may involve issuing new shares and diluting existing shareholders. Recent events, including filings and transcripts, do not indicate any major developments that would significantly impact the company's financial position or strategic direction. The company appears to be in a holding pattern, relying on its cash reserves while it works to improve its profitability.

30-day price · PLSM+98.00 (+8.8%)
Low$980.00High$1387.00Close$1218.00As of17 May, 00:00 UTC
Profile
CompanyPulsenmore Ltd
TickerPLSM.TA
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. Pulsenmore Ltd is a healthcare equipment company that develops and sells advanced medical equipment and technology, primarily generating revenue through product sales and related services.

Classification. Pulsenmore Ltd is classified under the Healthcare sector, specifically in the Advanced Medical Equipment & Technology industry, with a high confidence level of 0.92 based on verified market data.

Pulsenmore Ltd maintains a strong liquidity position, with a current ratio of 7.88 and cash and equivalents of 21.6 million ILS, indicating a robust ability to meet short-term obligations. The company's debt-to-equity ratio is 0.02, reflecting a conservative capital structure with minimal leverage. However, the company's price-to-book ratio of 80.61 suggests that the market is valuing the company significantly above its book value, which may reflect high expectations for future growth or innovation. The company's profitability metrics are concerning, with a negative return on equity of -19.08% and a negative return on assets of -15.57%, indicating that it is not generating returns for shareholders or effectively utilizing its assets. These figures are below the typical performance of the Advanced Medical Equipment & Technology industry, which generally expects positive returns due to the high-margin nature of medical equipment sales and services. Pulsenmore Ltd's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher risks if demand in its primary market fluctuates or if regulatory changes impact its operations. The company's growth trajectory is mixed. While it has a strong cash position, its operating and net income are negative, and its operating cash flow is -32.88 million ILS, indicating that it is not generating sufficient cash from operations to sustain its activities. The outlook for the current fiscal year does not indicate a significant improvement in these metrics, and the company may need to rely on its cash reserves to fund operations in the near term. Risk factors for Pulsenmore Ltd include the potential for dilution, although the risk is currently assessed as low. The company has not issued additional shares recently, and there are no immediate filing-based liquidity or dilution flags. However, the company's negative net income and operating cash flow could necessitate future financing, which may involve issuing new shares and diluting existing shareholders. Recent events, including filings and transcripts, do not indicate any major developments that would significantly impact the company's financial position or strategic direction. The company appears to be in a holding pattern, relying on its cash reserves while it works to improve its profitability.
Key takeaways
  • Pulsenmore Ltd has a strong liquidity position with a high current ratio and significant cash reserves.
  • The company is not currently profitable, with negative returns on equity and assets.
  • Revenue is concentrated in a single business segment, increasing exposure to market-specific risks.
  • The company's growth trajectory is uncertain, with negative operating and net income.
  • The risk of dilution is currently low, but the company may need to raise additional capital in the future.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyILS
Revenue$40.0M
Gross profit$33.7M
Operating income-$12.2M
Net income-$15.9M
R&D
SG&A
D&A
SBC
Operating cash flow-$32.9M
CapEx-$135.0k
Free cash flow-$13.1M
Total assets$101.8M
Total liabilities$18.8M
Total equity$83.1M
Cash & equivalents$21.6M
Long-term debt$1.6M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$1030.00
Market cap$6.70B
Enterprise value$6.68B
P/E
Reported non-GAAP P/E
EV/Revenue166.8
EV/Op income
EV/OCF
P/B80.6
P/Tangible book80.6
Tangible book$83.1M
Net cash$20.0M
Current ratio7.9
Debt/Equity0.0
ROA-15.6%
ROE-19.1%
Cash conversion2.1%
CapEx/Revenue-0.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Healthcare Equipment · cohort 160 companies
MetricPLSMActivity
Op margin-30.4%-24.0% medp25 -212.9% · p75 6.1%below median
Net margin-39.6%-20.7% medp25 -188.5% · p75 4.8%below median
Gross margin84.2%49.8% medp25 36.6% · p75 67.4%top quartile
CapEx / revenue-0.3%-4.7% medp25 -11.2% · p75 -1.8%top quartile
Debt / equity2.0%3.6% medp25 0.0% · p75 22.2%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-03 22:00 UTC#8cefafa7
Market quoteclose ILS 1030.00 · shares 0.01B diluted
no public URL
2026-05-03 22:00 UTC#bf0c9b56
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 22:02 UTCJob: 9159429e